Calamos Advisors
MDXG icon

Calamos Advisors’s MiMedx Group MDXG Stock Holding History

Calamos Advisors’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-216,064
Closed -$1.66M – 978
2024
Q1 		$1.66M Sell
216,064
-139,470
-39% -$1.12M 0.01% 600
2023
Q4 		$3.12M Buy
+355,534
New +$2.6M 0.02% 559

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Calamos Advisors's MDXG Position: Q2 2024 in Review

Calamos Advisors sold out of MiMedx Group (MDXG) in Q2 2024, closing a stake of 216,064 shares — an estimated $1.66M sold.

Calamos Advisors first reported a position in MDXG in Q4 2023 and held it in 2 quarters. The position peaked at $3.12M in Q4 2023. 202 funds tracked by Wall St. Rank hold MDXG as of Q2 2024.

  • Calamos Advisors reported no remaining MiMedx Group position as of Q2 2024 after selling out during the quarter.
  • Calamos Advisors sold 216,064 MiMedx Group shares in Q2 2024, an estimated $1.66M.
  • Calamos Advisors first reported a position in MiMedx Group in Q4 2023 and held it in 2 quarters.
  • Calamos Advisors's MiMedx Group position peaked at $3.12M in Q4 2023.
  • 202 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2024.

Based on Calamos Advisors's 13F filing for Q2 2024, filed 25 Jul 2024.